Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Alzheimer Disease × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 41 Neoplasms 34 Lung Neoplasms 22 Colorectal Neoplasms 22 Prostatic Neoplasms 15 Motor Activity 12 Uterine Cervical Neoplasms 11 Colonic Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Melanoma 8 Anxiety Disorders 8 Urinary Bladder Neoplasms 7 Obesity 7 Lymphoma 7 Hematologic Neoplasms 7 Head and Neck Neoplasms 6 Depression 6 Breast Carcinoma In Situ 6 Vulvar Neoplasms 5 Pain 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Endometrial Neoplasms 5 Stomach Neoplasms 4 Sarcoma 4 Papillomavirus Infections 4 Fatigue 4 Vaginal Neoplasms 3

Interventions

Electroencephalography 3 Dexamethasone 3 XENP 1595 2 pomalidomide 1 ixazomib 1 birtamimab 1 UE2343 1 Telemedicine 1 Tablets 1 Standard of Care 1 Rosiglitazone 1 Propofol 1 Positron-Emission Tomography 1 Neurofeedback 1 Methotrexate 1 Methods 1 Melphalan 1 Mass Screening 1 Magnetic Resonance Imaging 1 Lysine Acetyltransferase 5 1 Hypnosis 1 Hormones 1 Exercise 1 Ethanol 1 Drug Delivery Systems 1 Donepezil 1 Cyclophosphamide 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡